Cargando…

Insights Into the Pathogenesis of Bullous Pemphigoid: The Role of Complement-Independent Mechanisms

Bullous pemphigoid is an autoimmune blistering disease caused by autoantibodies targeting BP180 and BP230. While deposits of IgG and/or complement along the epidermal basement membrane are typically seen suggesting complement -mediated pathogenesis, several recent lines of evidence point towards com...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cole, Connor, Vinay, Keshavamurthy, Borradori, Luca, Amber, Kyle T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300999/ https://www.ncbi.nlm.nih.gov/pubmed/35874745 http://dx.doi.org/10.3389/fimmu.2022.912876

Ejemplares similares

Deciphering the Contribution of BP230 Autoantibodies in Bullous Pemphigoid
por: Cole, Connor, et al.
Publicado: (2022)

New Insights Into the Pathogenesis of Bullous Pemphigoid: 2019 Update
por: Genovese, Giovanni, et al.
Publicado: (2019)

Case Report: Combination of Omalizumab and Dupilumab for Recalcitrant Bullous Pemphigoid
por: Seyed Jafari, S. Morteza, et al.
Publicado: (2021)

Pterygium in bullous pemphigoid: An unusual complication
por: Haneke, Eckart, et al.
Publicado: (2020)

Effects of Omalizumab on FcεRI and IgE Expression in Lesional Skin of Bullous Pemphigoid
por: Seyed Jafari, S. Morteza, et al.
Publicado: (2019)

The Intersection of IgE Autoantibodies and Eosinophilia in the Pathogenesis of Bullous Pemphigoid
por: Messingham, Kelly N., et al.
Publicado: (2019)

Adaptive and innate immune pathogenesis of bullous pemphigoid: A review
por: Yan, Tianmeng, et al.
Publicado: (2023)

Tissue Destruction in Bullous Pemphigoid Can Be Complement Independent and May Be Mitigated by C5aR2
por: Karsten, Christian M., et al.
Publicado: (2018)

Complement-Activating Capacity of Autoantibodies Correlates With Disease Activity in Bullous Pemphigoid Patients
por: Chiorean, Roxana M., et al.
Publicado: (2018)

Bullous pemphigoid: The role of type 2 inflammation in its pathogenesis and the prospect of targeted therapy
por: Zhang, Luyao, et al.
Publicado: (2023)

Biological treatment for bullous pemphigoid
por: Oren-Shabtai, Meital, et al.
Publicado: (2023)

Elevated levels of interleukin-9 in the serum of bullous pemphigoid: possible association with the pathogenicity of bullous pemphigoid
por: Koga, Hiroshi, et al.
Publicado: (2023)

BP180 Is Critical in the Autoimmunity of Bullous Pemphigoid
por: Liu, Yale, et al.
Publicado: (2017)

Proinflammatory Cytokine Gene Polymorphisms in Bullous Pemphigoid
por: Tabatabaei-Panah, Pardis-Sadat, et al.
Publicado: (2019)

Case Report: The many faces of bullous pemphigoid
por: Rechtien, Laura, et al.
Publicado: (2023)

Commentary: Proinflammatory role of blister fluid-derived exosomes in bullous pemphigoid
por: Liu, Yangchun, et al.
Publicado: (2020)

Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid
por: Tasanen, Kaisa, et al.
Publicado: (2019)

Polymorphisms in the Mitochondrial Genome Are Associated With Bullous Pemphigoid in Germans
por: Russlies, Juliane, et al.
Publicado: (2019)

Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid
por: Zhang, Yihua, et al.
Publicado: (2021)

Emerging Biomarkers and Therapeutic Strategies for Refractory Bullous Pemphigoid
por: Zhou, Tong, et al.
Publicado: (2021)

Worldwide epidemiologic factors in pemphigus vulgaris and bullous pemphigoid
por: Rosi-Schumacher, Mattie, et al.
Publicado: (2023)

Comorbidity in bullous pemphigoid: up-date and clinical implications
por: Huttelmaier, Johanna, et al.
Publicado: (2023)

Bullous pemphigoid
por: Miyamoto, Denise, et al.
Publicado: (2019)

Assessment of the Characteristics and Associated Factors of Infectious Complications in Bullous Pemphigoid
por: Chen, Jia, et al.
Publicado: (2020)

Commentary: Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid
por: Wang, Si-Hang, et al.
Publicado: (2021)

Paradoxical phenomena of bullous pemphigoid induced and treated by identical biologics
por: Zhang, Jie, et al.
Publicado: (2023)

Bullous Pemphigoid and Other Pemphigoid Dermatoses
por: Pratasava, Valeryia, et al.
Publicado: (2021)

Case Report: A Rare Case of Pembrolizumab-Induced Bullous Pemphigoid
por: Zhang, Xiaoyan, et al.
Publicado: (2021)

Effect of early initiation of steroid-sparing drugs in patients with bullous pemphigoid
por: Fenne, Inger Johanne, et al.
Publicado: (2023)

The Autoimmune Skin Disease Bullous Pemphigoid: The Role of Mast Cells in Autoantibody-Induced Tissue Injury
por: Fang, Hui, et al.
Publicado: (2018)

The Role of Eosinophils in Bullous Pemphigoid: A Developing Model of Eosinophil Pathogenicity in Mucocutaneous Disease
por: Amber, Kyle T., et al.
Publicado: (2018)

Resolution in bullous pemphigoid
por: Sadik, Christian D., et al.
Publicado: (2019)

Esophageal Bullous Pemphigoid
por: Castelo Branco, Catarina, et al.
Publicado: (2022)

Dyshidrosiform Bullous Pemphigoid
por: Cohen, Philip R.
Publicado: (2021)

Cutaneous Dermatophytosis Mimicking Bullous Pemphigoid or Typical Bullous Pemphigoid and Tinea Incognito?
por: Andrés, Tirado-Sánchez, et al.
Publicado: (2019)

When Bullous Pemphigoid Is Not Bullous Pemphigoid: The Importance of Going Beyond Direct Immunofluorescence
por: Hopkins, Christina R, et al.
Publicado: (2022)

A Retrospective Study of Patient-Reported Data of Bullous Pemphigoid and Mucous Membrane Pemphigoid From a US-Based Registry
por: Lee, Janet, et al.
Publicado: (2019)

Rituximab, Omalizumab, and Dupilumab Treatment Outcomes in Bullous Pemphigoid: A Systematic Review
por: Cao, Peng, et al.
Publicado: (2022)

The gut microbiome in bullous pemphigoid: implications of the gut-skin axis for disease susceptibility
por: Liu, Xiaolin, et al.
Publicado: (2023)

Autoreactive Peripheral Blood T Helper Cell Responses in Bullous Pemphigoid and Elderly Patients With Pruritic Disorders
por: Didona, Dario, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_17ae7bbrc3123anpp7q6i5o09g